RecruitingPhase 3NCT06643130

Evaluate the Efficacy and Safety of Co-administration of JW0104+C2402 in Patients With Hypertension and Dyslipidemia

Studying Disorder of lipid metabolism

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
JW Pharmaceutical
Principal Investigator
Minjung Kim
JW Pharmaceutical
Intervention
JW0104+C2402(drug)
Enrollment
162 target
Eligibility
19 years · All sexes
Timeline
20242026

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06643130 on ClinicalTrials.gov

Other trials for Disorder of lipid metabolism

Additional recruiting or active studies for the same condition.

See all trials for Disorder of lipid metabolism

← Back to all trials